Stocks and Investing Stocks and Investing
Tue, January 31, 2017

Sumant Kulkarni Upgraded (TEVA) to Strong Buy on, Jan 31st, 2017


Published on 2024-10-25 20:08:11 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of B of A Securities, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy on, Jan 31st, 2017.

Sumant has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 5 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Downgraded from Buy to Hold on, Friday, January 20th, 2017
  • David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $42 on, Wednesday, November 16th, 2016
  • Tim Chiang of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, November 16th, 2016
  • Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016
  • Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016


This is the rating of the analyst that currently disagrees with Sumant


  • Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016

Contributing Sources